Reducing Disabilities in Alzheimer's Disease (RDAD) Translation in Area Agencies on Aging (AAAs)

Not Applicable

Completed

• Conditions: Alzheimer's Disease; Dementia; Memory Impairment; Cognitive Impairment
• Interventions: Behavioral: RDAD

• Registration Number: NCT01708304
• Lead Sponsor: University of Washington

Brief Summary

The University of Washington's Northwest Research Group on Aging is partnering with Area Agencies on Aging (AAA) in Washington and Oregon to complete this translational investigation of RDAD (Reducing Disabilities in Alzheimer's Disease). RDAD is an evidence-based program with demonstrated efficacy in helping older adults with dementia maintain physical function and remain physically and mentally healthy. This study asks two questions: 1) Can AAA partners successfully translate and implement RDAD, and 2) Is AAA implementation of RDAD effective in producing desired outcomes among agencies, providers, and older adults with dementia and their family members. This study is being conducted in Washington and Oregon states.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2012-10-09
• Study First Submitted QC: 2012-10-15
• Study First Posted: 2012-10-16
• Study Start: 2012-11
• Primary Completion: 2017-06
• Study Completion: 2017-06
• Status Verified: 2017-09
• Last Update Submitted: 2017-09-14
• Last Update Posted: 2017-09-15

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 510

Inclusion Criteria

Care Recipients must

• Have a diagnosis of dementia
• Be 65 years of age or older
• Currently exercise no more than 150 minutes a week and not regularly participate in a formal exercise program.

Caregivers must

• Live in the community
• Provide care to the care recipient with dementia

Read More

Exclusion Criteria

Either Care-recipient or Caregiver must not

• Plan to move to a long-term residential care setting within 6 months of enrollment.
• Plan to move from the study geographic area within 4 months of enrollment.
• Have a known terminal illness (with death anticipated within the next 12 months)
• Have had a hospitalization for a psychiatric disorder in the 12 months prior to baseline
• Be actively suicidal, hallucinating, or delusional
• Be blind, deaf, or not ambulatory

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
RDAD	RDAD	Exercise training for caregiver and care recipient. Behavior modification training for caregiver.

Primary Outcome Measures

Name	Time	Method
Minutes of exercise per week	Change from baseline in number of minutes of exercise each week during treatment phase of study, weeks 7-12	Caregivers will track the number of minutes per week the care recipients engage in exercise recommended by the coach.
Restricted Activity Days	Change from Baseline to Post-Treatment 2 (30 weeks)	Restricted Activity Days measures how much the participant cut down his/her usual activities in the previous two weeks because of injury or illness and how many days the participant stayed in bed in the previous two weeks because of injury or illness.
Independence/Residential Status	Change from Baseline to 13 Month Follow-Up	All participants will be in independent living situations at baseline. Any move from independent living to a care facility will be documented throughout the 13 month study.
Restricted Days of Activity	Change from Baseline to 13 Month Follow-Up	Restricted Activity Days measures how much the participant cut down his/her usual activities in the previous two weeks because of injury or illness and how many days the participant stayed in bed in the previous two weeks because of injury or illness.

Secondary Outcome Measures

Name	Time	Method
CES-D	Change from Baseline to 13 Month Follow-Up	A 20-item scale that assesses depression in caregivers.
Revised Memory and Behavior Problem Checklist (RMBPC)	Change from Baseline to 13 Month Follow-Up	Checklist rates 24 care recipient behaviors for frequency of occurrence and caregiver reaction.
Quality of Life-AD	Change from Baseline to 13 Month Follow-Up	This 13-item measure is specifically designed for individuals with dementia and focuses on quality of life domains identified as important for cognitively impaired older adults.

Trial Locations

Locations (1)

University of Washington; 🇺🇸 Seattle, Washington, United States